← Open Payments lookup

AMANDA LIVELY: Open Payments

NPI 1982064622 · PRICE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$847 in 42 payments from 20 companies in 2025. Trend: 2023 $603 · 2024 $578 · 2025 $847

Food & beverage: $847
CompanyPaymentsAmount
ABBVIE INC.13$265
AstraZeneca Pharmaceuticals LP5$93
PFIZER INC.3$56
Bayer Healthcare Pharmaceuticals Inc.3$55
Supernus Pharmaceuticals, Inc.2$45
Otsuka America Pharmaceutical, Inc.2$44
Biogen, Inc.1$26
Lundbeck LLC1$26
SANOFI-AVENTIS U.S. LLC1$26
Organon LLC1$25

Products named: VRAYLAR, UBRELVY, REXULTI, AIRSUPRA, Kerendia, Qelbree, QULIPTA, SKYCLARYS.

Industry payments across UT — which companies pay providers there.